Northcoast analyst Keith Housum downgraded Axon (AXON) to Neutral from Buy, stating that Axon’s “partner turned competitor” is “turning into a pain.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON: